The VELOCIMICE brand, founded in 2006 (United States), from 16 sister brands and 2214 competing brands. The VELOCIMICE brand is owned by Regeneron Pharmaceuticals, a company listed in New York. VELOCIMICE is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Regeneron Pharmaceuticals
(VELOCIMICE)
over 5 years*
USD 2,351.64